Polycystic ovary syndrome natural history, complications and prognosis
Polycystic ovary syndrome Microchapters |
Differentiating Polycystic ovary syndrome from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Polycystic ovary syndrome natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Polycystic ovary syndrome natural history, complications and prognosis |
FDA on Polycystic ovary syndrome natural history, complications and prognosis |
CDC on Polycystic ovary syndrome natural history, complications and prognosis |
Polycystic ovary syndrome natural history, complications and prognosis in the news |
Blogs on Polycystic ovary syndrome natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Natural History
If left untreated patients with PCOS can develop conditions depending upon underlying pathophysiology
- Increased levels of androgens, insulin resistance, and elevated cholesterol can lead to the heart disease.
- Increased lengths of time without a menstrual period leads to unopposed exposure of endometrium to estrogen can result in uterus cancer.
Complications
Complications that can develop as a result of polycystic ovary syndrome are:
- Endometrial hyperplasia and endometrial cancer
- Insulin resistance/Type II diabetes
- High blood pressure
- Dyslipidemia
- Cardiovascular disease
- Strokes
- Miscarriage
- Infertility
Prognosis
- The prognosis for fertility in patients with polycystic ovary syndrome is good with treatment, unless there are other unknown fertility problems.
- Regular follow-up is recommended to avoid ovarian hyperstimulation, multiple pregnancies, and endometrial hyperplasia.
- Patients should be counseled regarding the long-term risk of diabetes, hypertension, and endometrial hyperplasia, including the importance of maintaining a BMI <25 kg/m2and control of type 2 diabetes.